Craig Philips
President chez KINETA, INC.
Fortune : 44 391 $ au 31/05/2024
Profil
Craig W.
Philips is the founder of Abacus Bioscience, Inc. He currently holds the position of Chief Executive Officer & Director at Kv1.3 Therapeutics, Inc., and is also a Director at CBI Co., Ltd.
Additionally, he serves as President at Kineta, Inc. (Washington) and as Governor at Kineta Viral Hemorrhagic Fever LLC.
In his former positions, Mr. Philips was the President at CTI BioPharma Corp.
from 2008 to 2012.
Prior to that, he held the role of Vice President & General Manager at Bayer HealthCare Pharmaceuticals, Inc. from 2006 to 2008, and at Berlex Pharmaceuticals, Inc. from 2004 to 2006.
Mr. Philips obtained his undergraduate degree and an MBA from The Ohio State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KINETA, INC.
0,78% | 25/04/2024 | 95 465 ( 0,78% ) | 44 391 $ | 31/05/2024 |
Postes actifs de Craig Philips
| Sociétés | Poste | Début |
|---|---|---|
| CBI CO., LTD. | Directeur/Membre du Conseil | - |
| KINETA, INC. | President | 01/01/2013 |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | President | 01/01/2013 |
Abacus Bioscience, Inc.
 Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Fondateur | - |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Directeur Général | - |
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Craig Philips
| Sociétés | Poste | Fin |
|---|---|---|
| CTI BIOPHARMA CORP. | President | - |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Corporate Officer/Principal | 01/04/2008 |
| Berlex Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/12/2006 |
Formation de Craig Philips
| The Ohio State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CBI CO., LTD. | Producer Manufacturing |
| Entreprise privées | 8 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
| Berlex Pharmaceuticals, Inc. | |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Health Technology |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Health Technology |
Abacus Bioscience, Inc.
Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Health Technology |
| Kineta, Inc. |
